RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment...
Liquidia begins testing flu vaccine
News | 10. 06. 2010
Liquidia Technologies
Liquidia Technologies has started early clinical testing of its first vaccine developed using nanotechnology.
